Related Experiment Video
Updated: May 15, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Lipid metabolism reprogramming in chronic obstructive pulmonary disease.
Qianqian Liang1, Yide Wang1, Zheng Li2,3,4,5
1Fourth Clinical Medical College of Xinjiang Medical University, Urumqi, 830000, Xinjiang, China.
Fatty acid metabolism significantly impacts Chronic Obstructive Pulmonary Disease (COPD) development and progression. Reprogramming lipid metabolism offers a promising therapeutic strategy for managing this respiratory condition.
Area of Science:
- Respiratory Medicine
- Metabolic Research
- Molecular Biology
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a complex respiratory disorder with chronic cough, sputum, and wheezing.
- Pathologically, COPD involves inflammation, mucus overproduction, and alveolar damage.
- The exact causes of COPD are multifactorial and not fully understood.
Purpose of the Study:
- To clarify the role of fatty acid metabolism in COPD onset and progression.
- To explore lipid metabolism reprogramming as a potential therapeutic strategy for COPD.
Main Methods:
- Review of current literature on lipid metabolism and COPD.
- Analysis of cellular lipid modifications and their functions in COPD pathogenesis.
Main Results:
- Lipid metabolism is intricately linked to various metabolic pathways crucial for COPD pathogenesis.
- Specific alterations in lipid molecules and their functions are implicated in COPD.
Conclusions:
- Understanding fatty acid metabolism is vital for COPD research.
- Targeting lipid metabolism offers novel therapeutic avenues for COPD treatment.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

